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ABSTRACT 
This review examines current literature regarding relation ships between periodontal 
disease, oxidative stress and cardiovascular disease. Periodontitis refers to the chronic 
inflammation of gingival tissue associated with extensive dental plaque formation at the 
tooth and gingival interface. Previous studies have demonstrated an association between 
periodontal disease and risk of cardiovascular diseases such as atherogenesis and 
hypertension. Oxidative stress is implicated in the pathogenesis of many diseases and 
may provide a connection between periodontal disease and cardiovascular disease given 
that biomarkers related to the development of heart disease have diminished in patients 
with periodontitis after periodontal therapy. Several studies have examined the 
involvement of periodontitis and the role of oxidative stress in the initiation and 
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progression of hypertension. However, the relationship between periodontitis and the 
development of cardiovascular disease has not been fully elucidated. 
 
INTRODUCTION 
Periodontal disease is a group of chronic inflammatory diseases involving the 
periodontium, the soft tissue and mandibular bone surrounding the teeth. These 
diseases, including gingivitis and periodontitis, are among the most common dental 
diseases (1). Periodontitis is attributed to toxic products from pathogenic bacteria 
plaque and inflammation of gingival tissues elicited by the host response (2,3,4,5). 
Periodontitis is linked to an increased risk of cardiovascular diseases (CVD). The 
chronic inflammatory process of periodontitis and the host response provide the basis 
for the hypothetical association between periodontitis and CVD (6,7).  
Oxidative stress is an imbalance between oxidants and anti-oxidants molecules 
in favor of the oxidants, leading to adisruption of redox signaling and control and/or 
molecular damage caused by the presence of reactive oxygen species (ROS) (8). The 
cells have a mechanism of defense systems against oxidative  challenge. To maintain a 
steady-state of metabolites and functional integrity in the aerobic environment, 
antioxidant defense is organized to prevent, interceptionm and repair damage of tissues 
(8). 
ROS has been identified in a number of normal processes including intracellular 
oxygen metabolism, immune-mediated pathogen attacks and signal transduction/gene 
expression pathways and this is also involved in a number of human pathological 
conditions. Normal cells protect themselves from ROS using both enzymatic and non-
enzymatic antioxidants. For example, superoxide dismutase converts superoxide to 
molecular oxygen or hydrogen peroxide. Under certain circumstances, protective 
mechanisms can be inefficient at handling radicals/ROS, resulting in ‘oxidative stress’ 
(9). Several differentially localized and expressed enzyme systems contribute to ROS 
formation, including the nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidases, nitric oxide (NO) synthases, cytochrome P450 monoxygenases, and xanthine 
oxidase (10). Some biomarkers are used to indicate oxidative stress like carbonyls for 
protein damage, 8-OHdG for DNA damage, and isoprostanes for lipid peroxidation.  
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This review focuses on the role of reactive oxygen species in the relationship 
between periodontitis and the development of cardiovascular diseases. 
 
PERIODONTAL DISEASE AND ROS 
 
Some evidence shows that oxidative stress is implicated in the pathogenesis of 
many systemic and oral diseases such as periodontal disease (11). Oxidative stress by-
products, including lipid peroxidation, protein carbonyl levels and antibodies against 
ox-LDL (Ox-LDL), are significantly higher in individuals with periodontitis than in 
healthy controls, indicating excessive ROS production that probably results from local 
inflammatory responses (12,13,14,15,16,17,18). Additionally, reactive species and 
enzymes can be detected in the gingival crevicular fluid (GCF) of periodontal patients 
and used to differentiate oxidative stress in aggressive periodontitis and chronic 
periodontitis (CP) (19,20). GCF Malondialdehyde (MDA) levels were significantly 
higher in a generalized aggressive periodontitis (GAgP) group than in chronic 
periodontitis (CP) and control groups. Antioxidants such as superoxide dismutase 
(SOD), melatonin and glutathione have been investigated in human GCF. Patients with 
GAgP and CP present lower levels of SOD and melatonin than patients without 
periodontal disease (21,22). 
Some studies have shown that biomarker levels of oxidative stress in 
periodontitis patients are different from those of periodontal healthy subjects (19,20). 
MDA, SOD and melatonin levels in the gingival crevicular fluid of patients with 
chronic periodontitis and generalized aggressive periodontitis were considered 
biomarkers for oxidative stress (21). They also demonstrated that GCF-MDA levels 
were significantly higher in a GAgP group than in CP and control groups, and were 
significantly higher in the CP group than in the control group. SOD and melatonin GCF 
levels were significantly higher in a control group than in GAgP and CP groups and 
were significantly lower in a GAgP group than in a CP group. Another study, found 
higher levels of SOD serum and glutatione in a healthy group than in other groups. 
Post-treatment levels of SOD were statistically higher than pre-treatment levels in a 
periodontitis and gingivitis group (22).  
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Interestingly, the reduction in inflammatory levels caused by periodontal disease 
treatment changes the redox state of the patients. Scaling and root planing (SRP) change 
the total antioxidant status (TAS) and SOD activity in the saliva of periodontally 
compromised patients. TAS was higher in the saliva of patients with severe chronic 
periodontitis than in healthy or gingivitis control patients before SRP. SOD activity in 
periodontitis patients was lower than in the control during the experiment period (23). 
Similar results were obtained for serum and GCF. Periodontal therapy decreased SOD 
and TAS levels and improved antioxidant profiles in both GCF and salivary 
compartments (24,25). It is important to note that periodontal therapy not only changes 
SOD concentration but also intereferes with SOD activity. Patients with chronic 
periodontitis had higher mean SOD activity than that of control subjects. After therapy, 
median SOD levels in serum and saliva approached the median SOD level in a control 
group, indicating that non-surgical periodontal therapy significantly improves clinical 
parameters and restores previously increased SOD levels to normal in chronic 
periodontitis patients (26,27). In conclusion, periodontal disease changes the redox 
status of the  patient. 
 
THE IMPORTANCE OF NADPH OXIDASE IN CVD DISEASE 
 
Evidence showing the importance of vascular NADPH oxidase activity supports 
the relationship between ROS and CVD. Seven isoforms of NADPH oxidases are 
expressed in mammals: Nox1, Nox2, Nox3, Nox4, Nox5, Duox1 and Duox2. Four of 
these (Nox1, Nox2, Nox4 and Nox5) are most commonly expressed in vascular cells 
(10). Under physiologic conditions, vascular NADPH oxidases have a relatively low 
levels of constitutive activity. However, enzyme activity can be increased both acutely 
and chronically in response to stimuli such as inflammatory cytokines (28), growth 
factors (29), hyperlipidemia and high glucose (30), which disrupt vascular homeostasis 
and result in pathology.  Genetic heredity studies reinforce the importance of vascular 
NADPH oxidase in the vascular homeostasis. NADPH oxidase  subunits polymorphism 
was associated with increased arteriosclerosis. In particular, the -930(A/G) 
polymorphism in the p22 phox subunit could be related to hypertension, confirming the 
importance of NADPH oxidase (31). Genetic hereditary deficiency of NADPH 
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oxidases, particularly Nox2 (gp91phox), occurs in humans with chronic granulomatous 
disease (CGD). These patients have lower markers of vascular aging and oxidative 
stress (32). Significantly, these patients have lower levels of atherosclerosis burden, 
underscoring the possible role of vascular NADPH oxidase in atherosclerosis (33). 
 
PERIODONTAL DISEASE AND ATHEROGENESIS 
Infectious agents, including periodontal bacteria, have been implicated in the a 
etiology of various vascular conditions via multiple mechanisms, including direct 
microbial invasion of endothelial cells, that leads to entry of bacteria or their products 
into the blood stream (34). Following injury, endothelial cells initiate a series of pro-
inflammatory signals such as the release of chemokines, increased expression of cell 
adhesion molecules that promote attachment and transmigration of leucocytes into the 
vascular intima (35, 36). 
Activated leucocytes that have migrated into the subendothelial space continue 
the inflammatory cycle through production of additional pro-inflammatory cytokines, 
reactive oxygen species (ROS) and the release of tissue proteinases that degrade the 
surrounding extracellular matrix (34). 
            Links between periodontitis and atherosclerosis would be predicted based on 
inflammatory mechanisms initiated by bacteria associated with periodontal lesions, 
locally or systemically, that then influence the initiation or propagation of the 
atherosclerotic lesion (37). It has been hypothesized that oxidative stress arising from 
periodontal lesions may be an important cause of systemic inflammation. Abundant 
evidence has shown that oxidative stress caused by periodontal disease is strongly 
associated with several inflammation-related systemic diseases such as cardiovascular 
disease, type-2 diabetes and chronic inflammatory lung disease (10, 38, 39, 40, 41, 42). 
At physiological levels, reactive oxygen species act as signaling molecules that regulate 
a wide range of processes in the cardiovascular system and contribute to the 
maintenance of cardiovascular homeostasis. In contrast, excessive and sustained 
increases in ROS generation play a pivotal role in the initiation, progression and clinical 
consequences of CVD. As previously shown, periodontal disease is associated with 
increases in oxidative stress biomarkers (43,44). Bacterial pathogens, antigens, 
endotoxins, and/or inflammatory cytokines from periodontal lesions in the oral cavity 
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have been proposed as mechanisms that increase ROS production, atherogenesis and 
thromboembolic events and thereby increase CVD risk (45,46,43). An intrinsic 
mechanism can explain the role of ROS in atherogenesis. 
Specifically, low-density lipoprotein cholesterol (LDL) is slightly oxidized to 
modified LDL, which in turn stimulates smooth muscle cells and endothelial cells to 
produce monocyte chemoattractant protein-1 (MCP-1). Similarly, ROS increases the 
expression of ICAM-1 and VCAM-1 cell adhesion molecules and endothelial leukocyte 
adhesion molecules in endothelial cells (47,48). Further oxidation of LDL (OX-LDL) 
and MCP-1 promotes monocyte migration to subendothelial areas. Thus, monocytes 
differentiate into macrophages due to stimulus from the macrophage colony stimulating 
factor (M-CSF) released by endothelial cells. Macrophages generate enormous growth 
factors that lead to the proliferation of smooth muscle cells and synthesis of connective 
tissue that thickens vessel walls and results in the development and progression of 
atherosclerosis. In fact, excessive ROS production causes endothelial and smooth 
muscle dysfunction, which in turn leads to the progression of atherosclerosis (49,50). 
NO and H2O2 produce contractions in aortic rings isolated from rats (51,52). 
ROS can also induce the formation of endothelin-1, a vasoconstrictor. Endotlhelin-1, in 
turn, can control ROS production as a feedback mechanism (53,54). ROS also 
participates in the mechanisms of smooth muscle contractions by increasing 
intracellular calcium and inducing muscle contractions. Supporting this assertion, 
superoxide anions (55,56), H2O2 (55,57) and OH increase intracellular Ca2+ in 
cultured vascular endothelial cells. These species can induce vascular contraction 
directly via endothelin-1 or by reducing the bioavailability of nitric oxide, a vasodilator 
(58,59). ROS would reduce the production of the vasodilator prostacyclin by damaging 
the endothelial and reducing the capacity of the cells to convert arachidonic acid to 
prostacyclin (60).  
PERIODONTAL DISEASE AND HYPERTENSION 
 
Hypertension plays a key role in the development of CVD events such as cardiac 
and renal failure, stroke and myocardial infarction (61). It is believed that chronic 
inflammation associated with periodontitis could have hemodynamic influences and 
therefore impact hypertension pathogenesis and progression (62), through increased 
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endothelial dysfunction and arterial stiffness. Hypertensive patients produce 
significantly more plasma H2O2 than do normotensive subjects. In fact, ROS 
production increases in the vascular smooth muscle cells of resistance arteries in 
hypertensive patients, which is associated with upregulation of vascular NADPH 
oxidase (63,64). Additionally, normotensive subjects with family histories of 
hypertension naturally produce more H2O2, suggesting that some genetic disorders 
could lead to elevated H2O2 production (65,66). Interestingly, oxygen free radical 
levels are heritable, implying possible genetic disorders (67).  
Studies have shown that periodontal therapy in patients with severe periodontitis 
and hypertension had a positive effect on endothelial function (68). It was also 
demonstrated that periodontal treatment improved endothelial function and reduced 
markers of atherosclerosis in patients with CVD and /or diabetes (68,69,70).  
Single session of intensive periodontal treatment triggered a substantial increases 
in oxidative stress (assessed by circulating ROS) followed by a progressive reduction up 
to one month after therapy (71). 
 
CONCLUDING REMARKS 
  
Current epidemiological data show associations between cardiovascular disease 
and periodontitis. These associations would be predicted based on inflammatory 
mechanisms initiated by bacteria associated with periodontal lesions, locally or 
systemically, including reactive oxygen species produced during chronic periodontal 
inflammation that induce vascular changes causing atherogenesis and hypertension. 
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